Trial intelligence / Profile preview

Early intravenous versus delayed oral metoprolol in anterior ST-elevation myocardial infarction

2010-019939-35Phase 4Active

Sponsor
Centro Nacional de Investigaciones Cardiovasculares
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of metoprolol in myocardial infarction (MI) (2 arms), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Primary endpoints: Infarct size by cardiac magnetic resonance imaging, Change in left ventricular function by echocardiography and 1 more. Started May 2010; status: active.

02

Drugs

metoprolol
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2010-019939-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019939-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call